Koninklijke Philips Gross Margin 2012-2026 | PHG
Current and historical gross margin for Koninklijke Philips (PHG) over the last 10 years. The current gross profit margin for Koninklijke Philips as of June 30, 2026 is %.
| Koninklijke Philips Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-06-30 | $20.58B | $9.45B | 45.94% |
| 2026-03-31 | $20.43B | $9.24B | 45.20% |
| 2025-12-31 | $20.18B | $9.12B | 45.19% |
| 2025-09-30 | $19.08B | $8.67B | 45.44% |
| 2025-06-30 | $18.86B | $8.58B | 45.49% |
| 2025-03-31 | $18.81B | $8.44B | 44.85% |
| 2024-09-30 | $18.97B | $8.37B | 44.14% |
| 2024-06-30 | $18.60B | $8.01B | 43.07% |
| 2023-06-30 | $18.89B | $8.02B | 42.47% |
| 2023-03-31 | $18.85B | $7.90B | 41.90% |
| 2022-06-30 | $19.63B | $8.40B | 42.81% |
| 2021-06-30 | $20.30B | $8.95B | 44.10% |
| 2020-06-30 | $19.93B | $8.92B | 44.74% |
| 2019-06-30 | $22.93B | $10.37B | 45.23% |
| 2018-06-30 | $24.26B | $10.89B | 44.87% |
| 2017-06-30 | $25.77B | $11.36B | 44.09% |
| 2016-12-31 | $27.13B | $11.74B | 43.29% |
| 2016-09-30 | $27.08B | $11.37B | 41.99% |
| 2016-06-30 | $26.99B | $11.16B | 41.35% |
| 2016-03-31 | $26.98B | $11.06B | 40.98% |
| 2015-12-31 | $26.92B | $10.94B | 40.65% |
| 2015-09-30 | $26.06B | $10.57B | 40.57% |
| 2015-06-30 | $26.93B | $10.30B | 38.25% |
| 2015-03-31 | $27.58B | $10.53B | 38.18% |
| 2014-12-31 | $28.44B | $10.91B | 38.36% |
| 2014-09-30 | $30.72B | $12.09B | 39.34% |
| 2014-06-30 | $30.80B | $12.79B | 41.51% |
| 2014-03-31 | $30.92B | $12.86B | 41.58% |
| 2013-12-31 | $30.99B | $12.87B | 41.53% |
| 2013-09-30 | $31.41B | $12.81B | 40.79% |
| 2013-06-30 | $31.96B | $12.96B | 40.53% |
| 2013-03-31 | $31.77B | $12.40B | 39.03% |
| 2012-12-31 | $32.19B | $12.41B | 38.55% |
| 2012-09-30 | $31.35B | $11.51B | 36.71% |
| 2012-06-30 | $30.80B | $10.98B | 35.64% |
| 2012-03-31 | $31.11B | $11.41B | 36.67% |
| 2011-12-31 | $31.33B | $11.93B | 38.06% |
| 2011-09-30 | $32.59B | $12.73B | 39.06% |
| 2011-06-30 | $33.09B | $13.01B | 39.30% |
| 2011-03-31 | $33.49B | $12.98B | 38.75% |
| 2010-12-31 | $33.77B | $12.70B | 37.59% |
| 2010-09-30 | $34.44B | $14.15B | 41.09% |
| 2010-06-30 | $34.60B | $14.04B | 40.57% |
| 2010-03-31 | $34.14B | $12.71B | 37.23% |
| 2009-12-31 | $32.91B | $11.84B | 35.98% |
| 2009-09-30 | $32.42B | $9.86B | 30.41% |
| 2009-06-30 | $33.85B | $9.89B | 29.20% |
| 2009-03-31 | $36.52B | $11.69B | 32.01% |
| 2008-12-31 | $38.81B | $12.50B | 32.20% |
| 2008-09-30 | $40.05B | $13.18B | 32.91% |
| 2008-06-30 | $39.47B | $13.24B | 33.55% |
| 2008-03-31 | $37.59B | $12.69B | 33.74% |
| 2007-12-31 | $36.50B | $12.34B | 33.81% |
| 2007-09-30 | $35.52B | $13.74B | 38.67% |
| 2007-06-30 | $34.61B | $12.96B | 37.44% |
| 2007-03-31 | $35.94B | $13.28B | 36.94% |
| 2006-12-31 | $36.96B | $13.50B | 36.51% |
| 2006-09-30 | $37.80B | $12.02B | 31.81% |
| 2006-06-30 | $39.05B | $12.85B | 32.92% |
| 2006-03-31 | $39.12B | $13.29B | 33.97% |
| 2005-12-31 | $38.95B | $13.33B | 34.23% |
| 2005-09-30 | $44.75B | $16.72B | 37.36% |
| 2005-06-30 | $44.29B | $16.59B | 37.46% |
| 2005-03-31 | $43.45B | $15.89B | 36.56% |
| 2004-12-31 | $43.03B | $15.75B | 36.60% |
| 2004-09-30 | $36.64B | $9.99B | 27.27% |
| 2004-06-30 | $35.68B | $9.44B | 26.46% |
| 2004-03-31 | $34.33B | $8.87B | 25.84% |
| 2003-12-31 | $33.02B | $8.38B | 25.38% |
| 2003-09-30 | $31.21B | $7.87B | 25.22% |
| 2003-06-30 | $30.53B | $7.63B | 24.98% |
| 2003-03-31 | $30.46B | $7.33B | 24.06% |
| 2002-12-31 | $30.11B | $7.14B | 23.72% |
| 2002-09-30 | $29.48B | $-5.73B | -19.43% |
| 2002-06-30 | $28.64B | $-1.48B | -5.18% |
| 2002-03-31 | $27.92B | $3.14B | 11.25% |
| 2001-12-31 | $28.84B | $8.62B | 29.90% |
| 2001-09-30 | $30.28B | $3.48B | 11.48% |
| 2001-06-30 | $32.42B | $5.62B | 17.32% |
| 2001-03-31 | $34.35B | $7.54B | 21.95% |
| 2000-12-31 | $35.03B | $8.22B | 23.47% |
| 2000-09-30 | $35.19B | $10.44B | 29.68% |
| 2000-06-30 | $34.86B | $10.12B | 29.02% |
| 2000-03-31 | $33.97B | $9.22B | 27.14% |
| 1999-12-31 | $33.40B | $8.65B | 25.90% |
| 1999-09-30 | $31.72B | $31.72B | 100.00% |
| 1999-06-30 | $31.79B | $31.79B | 100.00% |
| 1999-03-31 | $32.99B | $32.99B | 100.00% |
| 1998-12-31 | $33.89B | $33.89B | 100.00% |
| 1998-09-30 | $37.85B | $37.85B | 100.00% |
| 1998-06-30 | $38.92B | $38.92B | 100.00% |
| 1998-03-31 | $39.01B | $39.01B | 100.00% |
| 1997-12-31 | $39.13B | $39.13B | 100.00% |
| 1997-09-30 | $39.39B | $39.39B | 100.00% |
| 1997-06-30 | $39.63B | $39.63B | 100.00% |
| 1997-03-31 | $40.14B | $40.14B | 100.00% |
| 1996-12-31 | $40.97B | $40.97B | 100.00% |
| 1996-06-30 | $28.53B | $28.53B | 100.00% |
| 1996-03-31 | $28.47B | $28.47B | 100.00% |
| 1995-09-30 | $38.67B | $38.67B | 100.00% |
| 1995-06-30 | $37.11B | $37.11B | 100.00% |
| 1995-03-31 | $35.48B | $35.48B | 100.00% |
| 1994-12-31 | $33.79B | $33.79B | 100.00% |
| 1994-06-30 | $22.52B | $22.52B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $24.651B | $20.173B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Medtronic (MDT) | Ireland | $119.983B | 16.40 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |